A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

The results of a clinical trial could signal a breakthrough in treating pancreatic cancer ...

The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.

Colorectal cancer is now officially the leading cause of cancer-related death among men and women 50 and younger, a significant increase from the 1990s, when it was the fifth deadliest. That’s ...

It’s tough to ignore the flurry of headlines decrying rising cancer rates, especially among young women and nonsmokers. But it seems now there is a reason for hope. According to the annual American ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...